Program Overview

Introduction to the Program

The School of Allied Health Professions and Nursing offers a module titled "Advancing Practice in Lung Cancer Management and Patient Care" (RADT760). This module is designed to allow learners to critically evaluate current and emerging strategies in the management and holistic care of patients with lung cancer.

Module Delivery

The module is delivered part-time, with the module delivered in one semester. The module runs in semester 2.

Key Dates and Application Information

• Apply by: 28 November 2025 (for semester 2)
• Module start date: to be confirmed
• Cost: £1300 (20 credits)

Target Audience

The module is designed for practising, registered healthcare professionals. The module can be used to support continuous professional development.

Module Details and Indicative Content

Learners will critically examine the professional policy, current guidance, and evidence base relating to the management of lung cancer. They will also critique the decision-making, risk assessment, and therapeutic intervention in relation to the management and holistic care of the lung cancer patient, and assess personal professional development in the field of lung cancer management through self-reflection.

Assessment

There are 2 summative assessments:

• Literature review, case study, or other (scope of practice dependent)
• Critical reflection of the learning journey To support summative assessment, there are opportunities to undertake formative assessment.

School Information

The School of Allied Health Professions and Nursing is part of the Institute of Population Health and the Faculty of Health and Life Sciences.

Program Structure

The program is structured to provide a comprehensive understanding of lung cancer management, including:

• Current strategies in lung cancer management
• Emerging trends and technologies in lung cancer care
• Holistic care approaches for lung cancer patients
• Decision-making and risk assessment in lung cancer management
• Therapeutic interventions for lung cancer patients